BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9009285)

  • 1. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection.
    Garvy BA; Ezekowitz RA; Harmsen AG
    Infect Immun; 1997 Feb; 65(2):373-9. PubMed ID: 9009285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia.
    Qureshi MH; Garvy BA
    J Immunol; 2001 May; 166(9):5704-11. PubMed ID: 11313412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.
    Chen W; Havell EA; Harmsen AG
    Infect Immun; 1992 Apr; 60(4):1279-84. PubMed ID: 1548057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice.
    Beck JM; Newbury RL; Palmer BE; Warnock ML; Byrd PK; Kaltreider HB
    J Lab Clin Med; 1996 Nov; 128(5):477-87. PubMed ID: 8900290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-gamma and type 1 and 2 TNF receptor genes.
    Rudmann DG; Preston AM; Moore MW; Beck JM
    J Immunol; 1998 Jul; 161(1):360-6. PubMed ID: 9647244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.
    Zhang ZQ; Wang J; Hoy Z; Keegan A; Bhagwat S; Gigliotti F; Wright TW
    Infect Immun; 2015 Dec; 83(12):4594-603. PubMed ID: 26371121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses.
    Garvy BA; Wiley JA; Gigliotti F; Harmsen AG
    Infect Immun; 1997 Dec; 65(12):5052-6. PubMed ID: 9393795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of interferon-gamma exacerbates pneumocystis-driven interstitial pneumonitis after bone marrow transplantation in mice.
    Garvy BA; Gigliotti F; Harmsen AG
    J Clin Invest; 1997 Apr; 99(7):1637-44. PubMed ID: 9120007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed inflammatory response to Pneumocystis carinii infection in neonatal mice is due to an inadequate lung environment.
    Garvy BA; Qureshi MH
    J Immunol; 2000 Dec; 165(11):6480-6. PubMed ID: 11086088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.
    Harmsen AG; Chen W; Gigliotti F
    Infect Immun; 1995 Jul; 63(7):2391-5. PubMed ID: 7790048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice.
    Wright TW; Johnston CJ; Harmsen AG; Finkelstein JN
    Am J Respir Cell Mol Biol; 1997 Oct; 17(4):491-500. PubMed ID: 9376124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection.
    Qureshi MH; Harmsen AG; Garvy BA
    J Immunol; 2003 Jan; 170(2):1002-9. PubMed ID: 12517967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice.
    Meissner N; Swain S; McInnerney K; Han S; Harmsen AG
    Am J Pathol; 2010 Jun; 176(6):2806-18. PubMed ID: 20395428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii.
    Chen W; Havell EA; Moldawer LL; McIntyre KW; Chizzonite RA; Harmsen AG
    J Exp Med; 1992 Sep; 176(3):713-8. PubMed ID: 1387414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection.
    Meissner NN; Swain S; Tighe M; Harmsen A; Harmsen A
    J Immunol; 2005 May; 174(9):5462-71. PubMed ID: 15843544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes.
    Beck JM; Warnock ML; Curtis JL; Sniezek MJ; Arraj-Peffer SM; Kaltreider HB; Shellito JE
    Am J Respir Cell Mol Biol; 1991 Aug; 5(2):186-97. PubMed ID: 1679991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased host resistance against Pneumocystis carinii pneumonia in gammadelta T-cell-deficient mice: protective role of gamma interferon and CD8(+) T cells.
    Steele C; Zheng M; Young E; Marrero L; Shellito JE; Kolls JK
    Infect Immun; 2002 Sep; 70(9):5208-15. PubMed ID: 12183572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
    Shellito JE; Kolls JK; Olariu R; Beck JM
    J Infect Dis; 1996 Feb; 173(2):432-9. PubMed ID: 8568306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latency is not an inevitable outcome of infection with Pneumocystis carinii.
    Chen W; Gigliotti F; Harmsen AG
    Infect Immun; 1993 Dec; 61(12):5406-9. PubMed ID: 7901169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody.
    Lund FE; Schuer K; Hollifield M; Randall TD; Garvy BA
    J Immunol; 2003 Aug; 171(3):1423-30. PubMed ID: 12874234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.